DCLK1 and clear cell renal carcinoma: In our previous studies of DCLK1 α-long functionality in clear cell renal cancer, we found that its expression strongly supports stemness as determined by 3D spheroid assays, drug resistance assays, and expression of well-described stem cell markers [21].